Comments
Loading...

CRISPR Therapeutics

CRSPNASDAQ
Logo brought to you by Benzinga Data
$50.59
12.03%
Last update: 11:00 AM
15 minutes delayed

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
0
0
0
0
Apr
1
4
May
1
1
Jun
2
Aug
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.9
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell
About
Sector
Healthcare
Industry
N/A
Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therap...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
CRSP

FAQ

Q

How do I buy CRISPR Therapeutics (CRSP) stock?

A

You can purchase shares of CRISPR Therapeutics (NASDAQ:CRSP) through any online brokerage.

View our list of the best stock brokerages

Q

Who are CRISPR Therapeutics (CRSP) competitors?

A

There are no as such competitors for CRISPR Therapeutics.

Q

What is the forecast, or price target, for CRISPR Therapeutics (CRSP) stock?

A

CRISPR Therapeutics has a consensus price target of $74.40.

Q

What is the current price for CRISPR Therapeutics (CRSP)?

A

The stock price for CRISPR Therapeutics (NASDAQ: CRSP) is $50.595 last updated September 19, 2024 at 11:00 AM EDT.

Q

Does CRISPR Therapeutics (CRSP) pay a dividend?

A

There are no upcoming dividends for CRISPR Therapeutics.

Q

When is CRISPR Therapeutics (NASDAQ:CRSP) reporting earnings?

A

CRISPR Therapeutics’s Q3 earnings are confirmed for Monday, November 4, 2024.

Q

Is CRISPR Therapeutics (CRSP) going to split?

A

There is no upcoming split for CRISPR Therapeutics.

Q

What sector and industry does CRISPR Therapeutics (CRSP) operate in?

A

CRISPR Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.